Enjoy complimentary customisation on priority with our Enterprise License!
The global kidney stones therapeutic market size is estimated to grow by USD 537.8 million at a CAGR of 4.96% between 2023 and 2028. The kidney stones therapeutic market is experiencing significant expansion, driven by several key factors. Firstly, the increasing preference for minimally invasive procedures, leading to the growing popularity of flexible digital ureteroscopes. Secondly, the rising incidence of urolithiasis, or kidney stones, is fueling market growth. According to the National Kidney Foundation, approximately 13% of the population will experience a kidney stone at some point in their lives. Lastly, the increasing prevalence of kidney stone disease, particularly in developed countries, is contributing to market expansion. With advancements in technology and a growing patient population, the kidney stones therapeutic market is poised for continued growth.
To learn more about this report, Download Report Sample
This report extensively covers market segmentation by type (ureteroscopy, lithotripsy, and percutaneous nephrolithotomy (PCNL)), end-user (hospitals, specialty clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2018 to 2022.
The market growth by the ureteroscopy segment will be significant during the forecast period. Ureteroscopy, which is also known as intracorporeal lithotripsy and retrograde intrarenal surgery (RIRS), is used if the stone size is up to 15 mm-20 mm in diameter and has moved into the ureter. This procedure has a high success rate when compared to lithotripsy.
Get a glance at the market contribution of various segments Download PDF Sample
The ureteroscopy segment was valued at USD 853.1 million in 2018. Vendors in the US offer technologically advanced ureteroscopes. For instance, Boston Scientific Corporation offers LithoVue single-use digital flexible ureteroscope, which delivers detailed high-resolution digital images. The use of single-use digital ureteroscopes in hospitals and clinics has increased when compared to reusable ureteroscopes due to the high capital expense of buying reusable ureteroscopes. The number of ureteroscopy procedures is estimated to account for more than half of the kidney stone treatment surgeries performed worldwide. Therefore, the URS segment is expected to dominate the global market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period.
The North American market growth is attributed to high demand for superior medical technology, increasing adoption of minimally invasive treatment options such as URS, the region's existing advanced medical infrastructure, and strong market presence of major providers.
In Canada, approximately 100,000 people out of every million will develop kidney stones at some point in their lives. Increasing public and private healthcare spending is also boosting the market growth. Moreover, the proportion of medical expenditures spent on treating kidney stones is steadily increasing in the region. North America dominates the market in terms of revenue and is expected to maintain its position over the forecast period. Canada accounts the large share of the North American market due to the rising prevalence of kidney stone disease, demand for high-quality medical technology, and increasing investment in the development of advanced.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The Market encompasses various treatments for managing kidney stones, including Urolithiasis, caused by Calcium oxalate, Cysteine, Uric acid, and Struvite. Diagnostic procedures such as Abdominal x-ray, Computed tomography, Ultrasound, Abdominal MRI, and Intravenous pyelography play a crucial role in identifying kidney stones. Olympus Corporation and other medical equipment manufacturers provide advanced technologies for minimally invasive procedures (MIS procedures), which include ureteroscopic and percutaneous renal lithotomy. Fast food consumption is a significant risk factor for calcium oxalate stones. Cooks and surgeons employ various techniques to remove kidney stones through open surgeries or extracorporeal methods. Side effects from these procedures can influence patient recovery and overall market trends. The market for kidney stones therapeutics continues to evolve, with a focus on minimally invasive procedures and advanced diagnostic technologies.
The Kidney Stones Therapeutic Market encompasses various treatments for managing kidney stones, including Urolithiasis, caused by Calcium oxalate, Cysteine, Uric acid, and Struvite. Diagnostic procedures such as Abdominal x-ray, Computed tomography, Ultrasound, Abdominal MRI, and Intravenous pyelography play a crucial role in identifying kidney stones. Olympus Corporation and other medical equipment manufacturers provide advanced technologies for minimally invasive procedures (MIS procedures), which include ureteroscopic and percutaneous renal lithotomy. Fast food consumption is a significant risk factor for calcium oxalate stones. Cooks and surgeons employ various techniques to remove kidney stones through open surgeries or extracorporeal methods. Side effects from these procedures can influence patient recovery and overall market trends. The market for kidney stones therapeutics continues to evolve, with a focus on minimally invasive procedures and advanced diagnostic technologies.
Key Driver
In the realm of kidney stones therapy, the market has witnessed significant progress, particularly in the area of ureteroscopy (URS). The advent of digital flexible ureteroscopes has revolutionized this field, offering several advantages over traditional fiber-optic ureteroscopes. These advanced instruments provide enhanced maneuverability and superior visibility, allowing for a clearer view of the entire collecting system in a greater number of cases. Moreover, the mean operating time for digital flexible ureteroscopes is shorter than that of fiber-optic ureteroscopes, while maintaining comparable stone clearance rates. It is noteworthy that fiber-optic ureteroscopes have a poor durability, with fibers more susceptible to breakage during ureteral passage and extreme deflection, such as during lower pole entry. This trend is expected to continue, driving the growth of the kidney stones therapeutic market.
Significant Trend
Kidney stones therapeutic market has witnessed significant advancements in the last three decades, driven by the innovation and refinement of various treatment procedures. In otolaryngology, lithotripsy, URS, and percutaneous techniques have revolutionized kidney stones treatment, surpassing the conventional open surgical methods. Holmium laser technology, miniaturized surgeries, and disposable ureteroscopes are the latest additions to this field, enhancing the efficiency and safety of stone removal. The holmium laser technology, in particular, has accelerated the adoption of URS due to its precision in targeting stones while minimizing damage to surrounding tissues. These advancements continue to shape the kidney stones therapeutic market, offering improved patient outcomes and quality of care.
Major Challenge
The global market for kidney stones therapeutics is witnessing significant growth, driven by the increasing prevalence of kidney stones and the subsequent demand for effective treatments. Urology, a specialized branch of medicine focusing on the urinary system, encompasses various procedures to manage kidney stones. The shortage of highly skilled urologists, however, poses a challenge to the delivery of optimal care for patients undergoing urological procedures. According to recent reports, the number of urologists is projected to decline by approximately 30% by 2025. This trend is attributed to several factors, including a decreasing interest among medical professionals to pursue urology as a specialty and the retirement of experienced surgeons. This shortage could potentially complicate kidney stone treatments and increase risks for patients. Effective training and education for urologists are essential to address this issue and ensure the successful implementation of advanced surgical techniques, such as laparoscopic and minimally invasive procedures. These methods have gained popularity due to their numerous benefits, including reduced recovery time, minimal scarring, and improved patient outcomes. Despite the challenges, the market for kidney stones therapeutics continues to expand, driven by advancements in technology and the growing demand for minimally invasive treatments. The development of new and innovative solutions is expected to further fuel market growth and improve patient care.
You may also be interested in:
Urology Devices Market - Urology Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2023-2027
Renal Biomarkers Market - Renal Biomarkers Market by End-user and Geography - Forecast and Analysis 2022-2026
Urethral Dilator Market - Urethral Dilator Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is significant due to the increasing prevalence of kidney stones worldwide. The market is driven by factors such as an unhealthy diet, sedentary lifestyle, and rising obesity rates. The market comprises various therapeutic options for kidney stones, including medications, extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PNL). These treatments aim to alleviate the symptoms and prevent the formation of new stones. Calcium oxalate is the most common type of kidney stones, and understanding its causes is crucial for developing effective therapeutic strategies. The market is expected to grow as the global population ages and the incidence of kidney stones increases. Additionally, advancements in technology and research are leading to new and improved treatment methods. The market for kidney stones therapeutics is dynamic and competitive, with various players offering innovative solutions to meet the evolving needs of patients.
The Kidney Stones market is significant due to the increasing prevalence of kidney stones worldwide. The market is driven by factors such as an unhealthy diet, sedentary lifestyle, and rising obesity rates. The market comprises various therapeutic options for kidney stones, including medications, extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PNL). These treatments aim to alleviate the symptoms and prevent the formation of new stones. Calcium oxalate is the most common type of kidney stones, and understanding its causes is crucial for developing effective therapeutic strategies. The market is expected to grow as the global population ages and the incidence of kidney stones increases. Additionally, advancements in technology and research are leading to new and improved treatment methods. The market for kidney stones therapeutics is dynamic and competitive, with various players offering innovative solutions to meet the evolving needs of patients.
The Kidney Stones Therapeutic Market encompasses a range of innovative solutions aimed at managing urolithiasis, a condition characterized by the formation of deposits of salt and minerals in the kidneys. Calcium oxalate stones are the most common type, accounting for approximately 80% of all kidney stones. Other types include struvite, cystine, and calcium phosphate stones. Patients suffering from urolithiasis require various interventions, including medical devices, drugs, and diagnostic tools. Stryker, Allengers, Medispec, Edap TMS, Sonomotion, and Dornier Medtech are some of the key players in this market, offering minimally invasive surgical techniques and advanced imaging systems like the Dornier Delta III and Optivision technology. Telemedicine and digital health solutions have emerged as crucial components in kidney stone management, enabling remote diagnosis and postprocessing of imaging data. Dietary interventions are also essential in preventing kidney stone formation. The rise in product innovations has led to the development of new drugs and technologies, although high treatment costs remain a significant challenge. Cook Technology, for instance, has introduced the Endoluxe system, which uses ultrasound waves to break down kidney stones. This technology, along with others, is transforming the urology market and improving patient outcomes. CT scans and Cystine stones are other critical aspects of kidney stone management. Overall, the Kidney Stones Therapeutic Market continues to evolve, driven by advancements in medical devices, diagnostic tools, and digital health solutions.
Kidney Stones Therapeutic Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.96% |
Market growth 2024-2028 |
USD 537.8 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.64 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, China, Germany, Canada, and UK |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors,market forecast, Competitive Strategies, and Industry Risks |
Key companies profiled |
Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd. |
Market dynamics |
Parent market analysis, market trends and analysis, market growth and trends, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.